Benjamin J Metcalf

Title: Benjamin J Metcalf: Innovator in Meningococcal Disease Prevention

Introduction

Benjamin J Metcalf, a prominent inventor located in Rochester, NY, has made significant contributions to the field of immunology with a total of 21 patents to his name. His work focuses on developing innovative solutions for the prevention and treatment of meningococcal disease, showcasing his dedication to advancing medical science.

Latest Patents

Among his latest patents, Benjamin has developed immunogenic compositions effective against meningococcal disease. His work specifically relates to ORF2086 proteins, which are cross-reactive immunogenic proteins that can be isolated from neisserial strains or prepared recombinantly. These compositions include immunogenic portions, biological equivalents, antibodies that bind specifically to these proteins, and nucleic acid sequences encoding them. The inventions offer promising uses in immunogenic compositions that are effective against infections caused by serogroup B.

Career Highlights

Throughout his career, Benjamin has worked with notable companies such as Wyeth Holdings Corporation and Serono Genetics Institute S.A. His experience in these organizations has played a pivotal role in shaping his expertise in immunological research and patent development.

Collaborations

In his professional journey, Benjamin has collaborated with esteemed colleagues like Leah Diane Fletcher and Robert J Zagursky. These collaborations have further enriched his research endeavors and contributed to his innovative outputs in the field.

Conclusion

Benjamin J Metcalf's contributions to the development of immunogenic compositions demonstrate his innovative spirit and commitment to advancing healthcare solutions. With his extensive portfolio of patents and collaborative efforts, he continues to be a key figure in the fight against meningococcal disease, paving the way for future advancements in immunology.